Found 473 articles for: "atopic dermatitis"
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis
October 2020 | Volume 19 | Issue 10 | Original Article | 956 | Copyright © October 2020
Mild to moderate atopic dermatitis (AD) occurs frequently in children and adults and is usually managed through the use of pharmacologic treatments, such as topical corticosteroids (TCS) and topical c...
Read MoreDevelopment and Evaluation of an Atopic Dermatitis Care Plan for Providers
October 2020 | Volume 19 | Issue 10 | Original Article | 950 | Copyright © October 2020
Background/Significance of problem: Atopic Dermatitis (AD) is a common, chronic, inflammatory dermatosis and skin disease that follows a relapsing pattern and requires a dynamic stepw...
Read MoreClinical Relevance of Skin Pain in Atopic Dermatitis
October 2020 | Volume 19 | Issue 10 | Original Article | 921 | Copyright © October 2020
Skin pain is increasingly recognized as an impactful symptom in atopic dermatitis (AD) because of its association with patient discomfort, disease burden, and reduced quality of life. Although the nat...
Read MoreThe Impact of COVID-19 on the Faces of Frontline Healthcare Workers
September 2020 | Volume 19 | Issue 9 | Original Article | 858 | Copyright © September 2020
As the coronavirus epidemic continues, a host of new cutaneous complications is seen on the faces of frontline healthcare workers wearing personal protective equipment on a daily basis. To minimize th...
Read MoreA Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants
August 2020 | Volume 19 | Issue 8 | Original Article | 769 | Copyright © August 2020
Background: Neonates and infants are susceptible to skin barrier disruption as their skin anatomically and functionally is still developing. The process of skin acidification plays a ...
Read MoreHalobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants
August 2020 | Volume 19 | Issue 8 | Original Article | 747 | Copyright © August 2020
Introduction: Psoriasis is a chronic, immune-mediated skin disease that is associated with sex-related differences. Two double-blind, vehicle-controlled, phase 3 studies evaluated hal...
Read MorePost-Inflammatory Hyperpigmentation: A Review of Treatment Strategies
August 2020 | Volume 19 | Issue 8 | Original Article | 763 | Copyright © August 2020
Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, ...
Read MoreRoflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study
August 2020 | Volume 19 | Issue 8 | Original Article | 734 | Copyright © August 2020
Background: Roflumilast cream (ARQ-151) is a highly potent, selective phosphodiesterase-4 inhibitor in development for once-daily topical treatment of chronic plaque psoriasis.
...
Read MoreDupilumab Improves Atopic Dermatitis and Post-Inflammatory Hyperpigmentation in Patient With Skin of Color
July 2020 | Volume 19 | Issue 7 | Case Reports | 776 | Copyright © July 2020
Atopic dermatitis, a chronic inflammatory condition, accounts for numerous dermatology visits for patients with skin of color. The inflammatory process often leads to post-inflammatory hyperpigmentati...
Read MoreObjective Evaluation of Skin Sensitivity Across Fitzpatrick Skin Types
July 2020 | Volume 19 | Issue 7 | Original Article | 699 | Copyright © July 2020
Context: Skin sensitivity may be best defined as self-reported intolerance to application of skincare products. It is commonly believed that individuals with darker skin are generally...
Read MoreA Review of Vitamin D and Scarring: The Potential for New Therapeutics
July 2020 | Volume 19 | Issue 7 | Original Article | 742 | Copyright © July 2020
Introduction: Recent research on vitamin D has shown that the fat-soluble micronutrient has anti-microbial, anti-inflammatory, and anti-proliferative effects in cells and tissues. Dur...
Read MoreConsensus on Neonatal Through Preadolescent Acne
June 2020 | Volume 19 | Issue 6 | Original Article | 592 | Copyright © June 2020
Background: Acne vulgaris is the most common dermatological disorder. Pediatric acne may be a manifestation of the underlying pathology and can occur in the first weeks, months, or ye...
Read MoreUnited States Stock Market Response to FDA Approval of New Dermatologic Drugs
June 2020 | Volume 19 | Issue 6 | Original Article | 639 | Copyright © June 2020
Background: The Food and Drug Administration (FDA) has approved several new dermatologic drugs in the last decade. The public response to their approval has not yet been evaluated.
Read More Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis
June 2020 | Volume 19 | Issue 6 | Original Article | 619 | Copyright © June 2020
Introduction: Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis (AD). This post hoc, pooled analysis id...
Read MoreBiologics and Small Molecules in the Treatment of COVID-19
June 2020 | Volume 19 | Issue 6 | Features | 673 | Copyright © June 2020
Non-Steroidal Topical Therapy for Facial Seborrheic Dermatitis
June 2020 | Volume 19 | Issue 6 | Original Article | 658 | Copyright © June 2020
Seborrheic dermatitis (SD) is a chronic, recurrent, inflammatory skin disorder occurring in areas rich in sebaceous glands. It manifests clinically as erythematous macules or plaques with varying leve...
Read MoreImportance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes
May 2020 | Volume 19 | Issue 5 | Original Article | 487 | Copyright © May 2020
Psoriasis is associated with physical, psychological, social, and economic burdens that lead to substantial impairment over a patient&rsqu...
Read MoreEffects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties
May 2020 | Volume 19 | Issue 5 | Original Article | 524 | Copyright © May 2020
Atopic dermatitis is characterized by dry, itchy, inflamed skin with a dysbiotic microbiome. In this clinical study (NCT03673059), we compared the effects of an eczema cream containing 1% colloidal oa...
Read MoreIs the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
April 2020 | Volume 19 | Issue 4 | Features | 436 | Copyright © April 2020
Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?...
Read MoreLight Emitting Diode Phototherapy for Skin Aging
April 2020 | Volume 19 | Issue 4 | Original Article | 359 | Copyright © April 2020
Skin aging is associated with changes that include atrophy, pigmentation, decreased ability for wound healing, and rhytides. Recently, there has been growing research interest and consumer demand for ...
Read More